vcvibes

Ghic Advisors, LLC

Global Health Security Fund, L.P.

Open, writing first checksEmerging manager

Open: first sale Apr 2024, per Form D (fund age approximates vintage)

Open their pitch form
Vintage
2024
Fund size
$272.59M (Form D)
Stages
Not stated
Sectors
Biotech, Medical devices
Regions
Global

01 · Thesis

Global Health Security Fund, L.P. uses venture capital to speed up the development and commercialization of technologies that respond to or prevent public health emergencies, such as pandemics. Its portfolio includes Aerska, a brain-targeted medicine delivery platform; Antheia, a biosynthesis manufacturing platform; Biolinq, a device; Cytovale, a cellular host response diagnostic; Prenosis, an AI-enabled diagnostic; and Terrestrial Bio, a biologic delivery company.

02 · Initial check

$2.73M to $4.54M (estimated from fund size)

Estimated from Form D

03 · Who to approach

Named on this fund's Form D

  • Labeeb Abboud, Chief Executive Officer of the General Partner of the Issuer
  • Charlie Petty, Managing Director of the General Partner of the Issuer
  • Vidya Vasu-Devan, Chief Investment Officer of the General Partner of the Issuer

04 · Deals

  • Aerska: Brain-targeted medicine delivery platform. source
  • Antheia: Biosynthesis manufacturing platform. source
  • Biolinq: Listed intervention: Device. source
  • Cytovale: Cellular host response diagnostic. source
  • Prenosis: AI-enabled diagnostic. source
  • Terrestrial Bio: Biologic delivery. source

05 · Evidence

  • Uses venture capital investments to accelerate development and commercialization of technologies that respond to or prevent public health emergencies.

    GHIC uses venture capital investments to accelerate the development and commercialization of technologies that respond to or prevent public health emergencies, such as pandemics and other global health security threats.
    https://ghicfunds.org/portfolio/

  • Aerska: Brain-targeted medicine delivery platform.

    Aerska Global Health Security Fund Intervention: Brain-targeted medicine delivery platform
    https://ghicfunds.org/portfolio/

  • Antheia: Biosynthesis manufacturing platform.

    Antheia Global Health Security Fund Intervention: Biosynthesis Manufacturing Platform
    https://ghicfunds.org/portfolio/

  • Biolinq: Listed intervention: Device.

    Biolinq Global Health Security Fund Intervention: Device
    https://ghicfunds.org/portfolio/

  • Cytovale: Cellular host response diagnostic.

    Cytovale GLOBAL HEALTH SECURITY Fund Intervention: Cellular host response diagnostic
    https://ghicfunds.org/portfolio/

  • Prenosis: AI-enabled diagnostic.

    Prenosis Global Health Security Fund Intervention: AI-enabled Diagnostic
    https://ghicfunds.org/portfolio/

  • Terrestrial Bio: Biologic delivery.

    Terrestrial Bio Global Health Security Fund Intervention: Biologic Delivery
    https://ghicfunds.org/portfolio/

06 · Sources

  1. https://ghicfunds.org/portfolio/
  2. https://www.sec.gov/Archives/edgar/data/2014822/000201482225000002/

Last verified: Oct 25, 2026